C ollaterals are interesting vessels. After sudden occlusion in brain, heart, and other tissues, collateral-dependent blood flow can lessen or prevent tissue injury, depending primarily on collateral number and diameter at baseline (collateral extent) and their subsequent amount of anatomic lumen enlargement, termed collateral remodeling or arteriogenesis. Unfortunately, flow provided by the pial collaterals, that is, leptomeningeal arteriole-arteriole anastomoses interconnecting distal branches of the middle cerebral artery (MCA), anterior cerebral artery (ACA), and posterior cerebral artery trees, varies widely among patients immediately after acute ischemic stroke. 1 Likewise, collateral flow also varies widely in heart and lower extremities of healthy individuals that lack detectable atherosclerosis.
C ollaterals are interesting vessels. After sudden occlusion in brain, heart, and other tissues, collateral-dependent blood flow can lessen or prevent tissue injury, depending primarily on collateral number and diameter at baseline (collateral extent) and their subsequent amount of anatomic lumen enlargement, termed collateral remodeling or arteriogenesis. Unfortunately, flow provided by the pial collaterals, that is, leptomeningeal arteriole-arteriole anastomoses interconnecting distal branches of the middle cerebral artery (MCA), anterior cerebral artery (ACA), and posterior cerebral artery trees, varies widely among patients immediately after acute ischemic stroke.
increased cerebral blood flow to the area at risk and reduced infarct volume each by 85%. 9 The Dce1 locus contains 28 protein-coding genes. 9 This study sought to identify the causative gene(s). We first verified that genetic background at Dce1 determines pial collateral extent and infarct volume by deriving an additional congenic line. This was followed by phenotyping collateral extent in mutant mice deficient at 13 of the above 28 genes, allowing their provisional elimination as candidates genes. Among the remaining 15 genes, we previously identified Rabep2 (Rabaptin-5β, FRA) as the highest priority candidate. 9 This was in part because it contains a SNP (rs33080487) that substitutes an adenine for a guanine in BC and almost all the other mouse strains with low collateral extent examined, resulting in an arginine-toglutamine (R298Q) substitution predicted to be deleterious. 9 We therefore hypothesized that variants of Rabep2 underlie the Dce1 locus and used gene editing to create B6 mice with either the BC SNP at rs33080487 or deletion of Rabep2 altogether. The results identify Rabep2 as the causative allele at Dce1.
Rabep2 is a novel gene. Our results show that variants of it alter collaterogenesis in the embryo and thus collateral extent and infarct volume in the adult. It is possible that the same or a related gene(s) may contribute to the wide collateral variation in humans, opening the way for the development of a biomarker for collateral extent, as well as a deeper understanding of why some patients with ischemic disease do better than others.
Methods
Mutant B6 mice were generated using CRISPR/Cas9 methodology: a guanine-to-adenine substitution (SNP), a 3-nucleotide deletion (Del3), a 1-guanine insertion (InsG), or a 1-guanine deletion (DelG) at rs33080487 (7:126 440 209) in Rabep2. Pial collaterals between the MCA and ACA trees were quantified in 3-to 4-month-old adults after maximal dilation and in embryos by immunohistochemistry/ fluorescence. Infarct volume was determined 24 hours after pMCAO. Endosomes were measured with immunohistochemistry in embryonic pia. Neonatal retina, tumor, and aortic ring angiogenic assays were standard, as were quantitative polymerase chain reaction, immunoblot, immunoprecipitation, mass spectrometry, and genotyping. This study conformed to the recommendations of STAIR (2012; in the online-only Data Supplement). Data are mean±SEM with significance (P<0.05) determined by ANOVA, Student, and Bonferroni t tests. Methods are available in the online-only Data Supplement.
Results

A Refined Interval Containing Dce1 Narrows the Candidate Genes Underlying Collateral Variation
During backcrossing CNG5 to BC mice, we obtained a recombination that deleted 550 kb from CNG5 such that the introgressed region is 162 kb longer than the originally defined Dce1 ( Figure I in the online-only Data Supplement). This CNG7B6 line has on average 13.0 pial collaterals (MCA-ACA) per individual, compared with 0.7 in CNG7BC littermates and 19 to 20 in B6 (Figure 1) . Thus, the B6 allele of Dce1, when introgressed into BC, rescues 12 to 13 collaterals or ≈65% of the BC deficit in collateral number. Similarly, pial collaterals in CNG7B6 are almost 2-fold larger in diameter and infarct volumes after pMCAO than in CNG7BC littermates (Figure 1) . These values are similar to those reported previously for lines CNG3, CNG5, and CNG6 and their CNGBC littermates ( Figure 1) . 9 These data confirm our previous conclusion 9 that a genetic element(s) in Dce1 is responsible for ≈80% of the variation in collateral extent and infarct volume between B6 and BC mice. However, it should be pointed out that in mice, multiple branching of the MCA can also be associated with small infarction volumes in suture models.
We did not examine infarct volume in the CNG6 line previously characterized 9 and since extinguished. This prevented us from addressing a recent report that a variant lying 3′ to Dce1 does not affect collateral extent but is protective against infarct volume when of B6 genotype. 10 We were unable to confirm this conclusion: infarct volume did not decrease but instead trended greater between CNG7B6 that lacks, and CNG5B6 and CNG3B6 that possess, B6 genome 3′ to Dce1 that includes the reported protective allele (Figure 1 ). One explanation is that the distal locus requires the presence of additional genetic material not present in our congenic lines.
To narrow the 28 protein-coding gene candidates in Dce1, 9 we phenotyped collateral extent in available knockout mice. 
Variants of Rabep2 Confer Variation in Collateral Extent
Among the 28 genes in Dce1, a nonsynonymous coding SNP (rs33080487, 7:126440209 [GRCm38], c.1258G>A in BC) causes the alteration R298Q in the Rabex5-binding domain 11 of Rabep2 (NP_085043.2), an alteration predicted to be deleterious by PolyPhen-2 (score=0.999). We thus edited this polymorphism into B6 mice (SNP line). Presumptive nonhomologous end-joining gave 3 additional lines (Table I and Figure IV in the online-only Data Supplement). Two lines, DelG and InsG, have a deletion and insertion, respectively, of one nucleotide leading to frameshift, stop codons, and predicted nonsense mediated decay. In the third line, Del3, the codon for R298 was deleted, leading to expression of full-length Rabep2 minus R298. Quantitative polymerase chain reaction of DelG confirmed that Rabep2 message was reduced to 15% of wild type (WT), with the residual presumably reflecting message that had not yet undergone nonsense mediated decay. Rabep2 expression was assessed ( Figure 2A ). Whole brain and neocortex from WT and DelG mice probed with 2 specific rabbit sera (gifts of Dr M. Zerial) showed Rabep2 to be undetectable in DelG (Figure 2A, top) . A commercial antibody (Proteintech 14625-AP) revealed several closely spaced bands in WT, BC, SNP, and Del3, although the lower band in DelG and InsG was absent. A pulldown from WT with this antibody yielded the lower band. Mass spectrometry (matrixassisted laser desorption/ionization and LTQ-Velos-Orbitrap) confirmed that the product was Rabep2. We were unable to pull down enough of the upper 2 bands to get a definitive identification. However, mass spectrometry analysis showed that they are not Rabep2. Hence as predicted, both DelG and InsG mice are knockouts, although expression of Rabep2 in SNP and Del3 seems to be unaffected. Rabep1 levels by (Table II in the online-only Data Supplement) and had normal growth. Founders were outcrossed to additional B6 for 2 to 5 generations, all WTs were littermates, and their values of collateral number and diameter were similar to our previous WT-B6, [6] [7] [8] [9] indicating no off-target effects. Collateral number was reduced to 8.0 collaterals in homozygous DelG and InsG mice, a deficit of 11 to 12 collaterals compared with WT littermates and WT-B6 ( Figure 2C) . Thus, the reduction in collateral number because of the elimination of Rabep2 from B6 is virtually identical to the increase in collateral number caused by introduction of the B6 allele of Dce1 into BC, suggesting that variants of Rabep2 alone account for the entire effect of Dce1. Similarly, collateral diameter was reduced by 41% and 47% in DelG and InsG knockouts, representing 85% and 97% of the difference in diameter attributable to Dce1 ( Figure 2B ). This stronger effect on diameter than on number was previously noted for Dce1, 9 where expression of the B6 allele in BC essentially restored diameter to the WT-B6 value.
Alterations at position 298 with retention of Rabep2 expression gave intermediate reductions in collateral number to 13.0 in Del3 (delR298) and 12.3 in SNP (R298Q). Thus, Rabep2 activity in these forms seems to be diminished, and variation at position 298 has less effect on the B6 background (reduction of 6-7 collaterals for R298Q) than on the BC background (rescue of 12-13 collaterals by R298Q). Diameter data yield similar conclusions ( Figure 2B ), although the difference between alteration and elimination of Rabep2 is less striking ( Figure 2B ). As expected, these changes in collateral extent have functional effects because infarct volumes after pMCAO were increased 2-to 3-fold in DelG and SNP mice ( Figure 2D 
Rabep2 Favors Greater Collateral Extent and Smaller Infarcts in B6 Females
Infarct volume was 35% smaller in female B6-WT; this difference was abolished in Rabep2 −/− mice in association with a trend toward fewer collaterals of smaller diameter (Table  III in the online-only Data Supplement). Thus, on the B6 background, the B6 allele of Rabep2 favors greater collateral 
Variants of Rabep2 Alter Collaterogenesis
Pial collateral extent in healthy adults is dependent on collateral formation in the embryo (ie, collaterogenesis). 7 Consistent with this, collaterogenesis was inhibited at both E14.5 and E16.5 in Rabep2 −/− mice, indicating that Rabep2 is required for robust collateral formation ( Figure 3A) . Likewise, CNG5B6 embryos formed more collaterals than CNG5BC, confirming that the B6 variant (of presumably Rabep2) increases collaterogenesis when on the BC background ( Figure 3B ). Consistent with diameter being larger and branch density lower for pial capillary plexus vessels of BC versus B6 embryonic neocortex, 7 diameter was greater and branch number lower in Rabep2 −/− ( Figure 3C ), indicating that Rabep2 also impacts vascular patterning. Previous studies have observed these same differences in the early embryonic capillary plexus of BC versus B6 and Vegfa and Flk1 mutants and shown that the accompanying differences in collaterogenesis are not secondary to the differences in the plexus, as reported in Lucitti et al 7 and references therein. Consistent with developmental and adult angiogenesis (sprouting of new capillary vessels from existing capillaries) being comparable in B6 and BC mice, 7 angiogenesis in the newborn retina was similar in CNG5B6 and CNG5BC mice 
Rabep2 Deficiency Alters Endosome Trafficking
Little is known about the function of Rabep2 other than it binds activated Rabex5, Rab5, and Rab4 proteins during early endosome (EE) formation in cultured cells. 12 Endosomes traffic receptors such as VEGFR2 to sites involved in downstream signaling, lysosomes, or back to the cell membrane. [13] [14] [15] We thus examined EEs in pial membrane of Rabep2 −/− mice at E14.5 when collaterogenesis is underway. Endosome diameter was larger in Rabep2 −/− , although density was similar ( Figure 5A through 5C). The requirement to examine EEs in situ precluded assessment of colocalization of VEGFR2 with EEA1. However, Vegfa expression, Vegfr2 expression, and Vegfr1 expression were similar between groups ( Figure 5D ), suggesting that aberrant levels of these proteins do not underlie the reduced collaterogenesis in Rabep2 −/− mice. Deficiency of Rabep2 had no effect on Rabex5 and Rab4 that Rabep2 is known to bind, nor on EEA1 or Rab7 which are present in late endosomes destined for recycling to the cell membrane ( Figure 6A ). These proteins are in the VEGFA→VEGFR2→endosome→VEGFR2 recycling and signaling pathways (Discussion). These findings, which are consistent with lack of effect on expression of VEGFA, VEGFR2, and VEGFR1 ( Figure 5D ), strengthen the conclusion from Figure 5A through 5C that Rabep2 deficiency impairs endosome trafficking. Capillary and microvessel densities in adult brain were not affected by Rabep2 deficiency ( Figure 6B ; Figure VIII in the online-only Data Supplement). This is consistent with data in Figure 4 and Figure VII in the online-only Data Supplement showing that angiogenesis was not altered in newborn retina, tumor growth, or aorta explants, reinforcing the conclusion that Rabep2 is important in the collaterogenic but not angiogenic pathways. Other genetic abnormalities have been associated with changes in capillary density, for example, Notch3 mutants with differences in pericyte coverage 16, 17 and aged mice harboring the human APP-Tg2576 transgene. 18 However, expression of Notch3 was not different between CNG7BC and CNG7B6 mice (3 biological replicates done in triplicate and repeated 3×, P>0.8; data not shown).
The A-to-G SNP Present in 129 Background Mice Recapitulates the CNG Phenotype
Before deriving Rabep2 edited mice, we examined Nfatc2ip knockouts (a gift from Dr K. Mowen).
19 Nfatc2ip −/− mice were made using 129/SvJae embryonic stem cells and backcrossed 6 to 12 generations to BALB/c. Genotyping identified that a 129Sv flanking region was retained that included Rabep2 with the B6 allele at rs33080487 (Figure III in the online-only Data Supplement). High-density SNP array analysis (GigaMUGA) confirmed the presence of ≈3 Mb of 129 derived sequence around targeted Nfatc2ip (≈7:125221537-128681374), extending well beyond Dce1 in both directions. Consistent with the presence of the B6 Rabep2 allele, Nfatc2ip −/− had 70% of collateral number and 93% of diameter of the difference attributable to the Dce1 locus evident in Figure 1 . Likewise, they had the small infarct volume of B6-WT (Figures 1 and 2 ; infarct volumes were comparable, P=0.42; Figure IIIA through IIIC in the online-only Data Supplement). These values, which were reported previously 9 and do not significantly differ from the CNG lines in Figure 1 , 9 confirm on a different background (BC) the major role of Rabep2 and SNP rs33080487 in collaterogenesis. These findings also show no contribution of Nfatc2ip.
Having identified Rabep2 as causal for Dce1, we combined new high-resolution SNP data (Sanger-1, Jackson Laboratories) with our own sequencing across Rabep2 to clarify uncertainties among 21 strains we previously phenotyped. 6 Collateral phenotype now correlates almost exactly with genotype among 20 of 21 strains ( Figure 6C ; Table IV in the online-only Data Supplement); we also identified 3 new SNPs in the lone SJL/J outlier strain that could reconcile its phenotype to Dce1 (Table IV in the online-only Data Supplement footnotes).
Discussion
Collateral status has been proposed to be important in defining the course after treatment in acute ischemic stroke. 20, 21 However, collateral flow varies widely among patients for largely unknown reasons. [1] [2] [3] [4] Recent studies in mice have provided a potential clue. [5] [6] [7] [8] [9] Strains with differences in genetic background exhibit wide variation in collateral extent, ≈80% of which depends on a polymorphic region on chromosome 7, Dce1. 6, 8, 9 In this study, we demonstrate that a single gene within this region, Rabep2, is responsible for this variation. However, its contribution varies depending on genetic background. When the BC allele of Rabep2 is on the B6 background, it accounts for 36% and 72% of the differences in collateral number and diameter attributable to Dce1-as determined in the SNP and genetically comparable Del3 miceand accounts for 64% and 89% of number and diameter when it is deleted as in the Rabep2 −/− mice. By comparison, when the B6 allele is present on the BC background (CNG7B6 and Nfatc2ip −/− mice), it rescues 70% and 93% of number and diameter in WT-B6 mice. These values are identical to those reported previously 9 and make clear that other genetic elements interact with Rabep2 or contribute independently to collateral variation.
Rabep2 is a ubiquitously expressed gene about which little is known. Studies in cultured cells show that Rabep2 participates in vesicular trafficking 12 wherein cell surface receptors are internalized into vesicles that fuse into EEs in a Rab4-and Rab5-dependent manner.
12-15 Membrane cargo is then 
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December 2016 returned to the plasma membrane via recycling endosomes (Rab4 dependent), concentrated in Golgi-associated stores, or transferred to lysosomal-bound late endosomes (Rab7 and Rab9 dependent). 15, [22] [23] [24] EE formation requires recruitment of Rab4, Rab5, and several Rab effectors. However, compared with the better known Rabep1 which when immunodepleted in HUVEC results in severe disruption of EE fusion, depletion of Rabep2 has only a minor effect which may explain why no functional studies have appeared since its original description.
12
Rabep2 shares 42% sequence identity and 53% similarity with Rabep1. Although they complex with some of the same proteins, there is no evidence that they directly interact. 12 Similar to Rabep1, Rabep2 is recruited to EEs by Rab4 and Rab5 GTPases and Rabex5 (RabGEF1), where it complexes with other endosomal proteins. 12, 13, 15 Redundancy exists for Rabep1 because overexpression of other binding partners can compensate for dysfunctional trafficking caused by deleting its binding domains. 15 The B6-BC amino acid change (rs33080487) is in the coiled-coil domain of Rabep2 that enables binding to Rabex5 (CC2-1, Figure 6C ). Deleting the homologous domain of Rabep1 prevented its recruitment to EEs. 15 Accordingly, it is possible that the R298Q change alters binding of Rabep2 to Rabex5 and hinders Rab4 or Rab5 activation and that deletion of Rabep2 −/− further impairs activity. Consistent with this hypothesis, we observed larger endosomes in Rabep2 −/− embryonic pia. This suggests that in Rabep2 −/− , EEs initially form and fuse into larger vesicles (Rab5 function remains intact) but recycling is reduced because Rab4 action is hindered.
It is well established that VEGFR2 undergoes liganddependent and ligand-independent (constitutive) endocytosis, [25] [26] [27] [28] and that these signaling routes impact angiogenic sprouting and vascular development. 29, 30 Binding of VEGFA induces VEGFR2 trafficking through one of the several pathways, including the Rab4-mediated short-loop fast-recycling route back to the cell membrane via EEs. Whether endocytosis enhances or dampens VEGFR2 signaling seems to be context dependent. For example, downstream VEGFR2 effectors mitogen-activated protein kinase and AKT required for VEGFA angiogenic actions show sustained activation in endothelial cells when EE formation is impaired, 15 suggesting that endocytosis is required for VEGFR2 signaling. In contrast, ligand binding causes ubiquitination of VEGFR2 thus targeting for lysosomal degradation. 26 Further complicating matters, presumed newly synthesized VEGFR2 stored in the Golgi can be, after VEGF-VEGFR2 binding to vesicles, quickly mobilized/targeted to either the cell membrane or lysosomes, 31 and existing endosomes from plasma membrane can fuse with the Golgi. 22 The signals that dictate where/when VEGFR2 is shuttled remain under investigation.
VEGFA→VEGFR2 signaling contributes importantly to embryonic collaterogenesis. 7 Reduction of ligand or receptor during the narrow time window of collaterogenesis reduces collateral formation, thus collateral number and diameter in the adult. 7 Herein, we found that the embryonic pial plexus of Rabep2 −/− mice had larger vessel diameters and less branching. This phenocopies previous findings in Vegfa-deficient and BC mice (compared with B6), the latter being consistent with reduced Vegfa expression in BC versus B6 mice reported in Lucitti et al 7 and references therein. Because Vegfa, Vegfr2, and Vegfr1 transcripts were not decreased, and EEs were larger in E14.5 Rabep2
−/− mice, we hypothesize that when Rabep2 is lacking, deficient EE recycling sequesters inactive VEGFR2, effectively reducing the number available for signaling, with the result that collaterogenesis is reduced. Significant perinuclear VEGFR2 is evident in pial endothelial cells of E14.5 embryos (data not shown); thus, transport from this location to the cell membrane may also be impaired.
Arteriogenesis, that is, anatomic enlargement of collateral lumen diameter that occurs after arterial obstruction (eg, pMCAO), is induced by shear stress. 32 It is possible that the difference in arteriogenesis between these strains 33 contributed to infarct volumes measured in this study. However, we previously showed that this difference maps to a quantitative trait locus on chromosome 11 different from Dce1/Rabep2 on chromosome 7. 8 In agreement, introgression of Dce1 between the 2 strains had no effect on arteriogenesis of pial collaterals after pMCAO or hindlimb collaterals after femoral artery ligation. 9 In addition, differences in infarct volume reported previously 9 and in this study closely follow the genetically engineered differences in native collateral extent.
This study has several limitations. First, determining how altered Rabep2 disrupts collaterogenesis will be challenging because there is no in vitro model of collaterogenesis, mice with transgenic, marker, and conditional alleles of Rabep2 will have to be constructed, and little is known about the functions of Rabep2. Second, although effective in our immunoblot and pulldown assays, available Rabep2 antibodies showed significant nonspecific binding that precluded their use for 12 de Renzis et al, 13 and references therein. We confirmed nonsynonymous SNPs in strains LEWES/EiJ (P200R), A/J (R426H), SJL/J (R298Q), and SWR/J (R298Q). Ubiquitination and phosphorylation sites are predicted (Phosphosite.org) and were confirmed for Lys92 and Ser180 by proteomics. CC indicates coiled-coil sequence. by guest on July 23, 2017 http://stroke.ahajournals.org/
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immunohistochemistry-findings we confirmed with mass spectrometry. Third, the importance of variants of Rabep2 in determining variation in collateral extent in mouse may not translate to human. However, because vascular developmental pathways are conserved among vertebrates, and mice and humans are 92% similar genetically, it is possible that polymorphisms at human RABEP2 are significant determinants.
Other collateral genes are also likely important: 3 additional quantitative trait locus have been identified that account for almost all of the remaining variation in pial collaterals between B6 and BC mice beyond Rabep2, 8 and several known angiogenic proteins significantly impact collaterogenesis, thus collateral extent, in pia and skeletal muscle (VEGFA, VEGFR2, Dll4, Notch, ADAM10, ADAM17, and Gja4, Gja5) 7, [34] [35] [36] and possibly others (Egln1 37 and NFkB1 38 ). Last, we have previously reported in mice that aging, impaired eNOS activity, hypertension, metabolic syndrome, and other cardiovascular/stroke risk factors cause a reduction in pial collateral number and diameter, in association with increased infarct volume after pMCAO as reported in Moore et al 5 and references therein. However, these environmental effects on collateral extent are smaller than those attributable to differences in genetic background.
Our findings regarding Dce1, Rabep2 and collaterals have recently been confirmed: P. Quax and coworkers (personal communication, 2016) examined a region on chromosome 7 in B6 versus BALB/c mice known to harbor variants of several genes resulting in differences in natural killer cell function. A similarly large reduction in pial collateral number was found in a B6 line in which the BALB/c variant of the natural killer cell locus had been introgressed during construction of a mutant line. While at first suggesting involvement of this locus in collateral variation, subsequent analysis identified that the flanking region of the natural killer cell locus contained the BALB/c variant of Dce1.
Summary/Conclusions
Collateral-dependent blood flow after stroke is primarily determined by collateral extent at baseline and the amount of collateral remodeling/arteriogenesis after large artery occlusion. Herein, we show that Rabep2 is the causal gene at Dce1 responsible for most of the difference in native collateral extent in B6 and BC mice and, by inference based on previous SNP association studies 8 and new SNPs we identified herein, in 18 of the 19 other strains examined. Whether this extends to humans is under investigation in a prospective study, GENEDCSS (Genetic Determinants of Collateral Status in Stroke, J.E. Faber, PhD, personal communication, 2015). Confirmation that RABEP2 and other collateral genes link to variability in collateral status may lead to development of a test to identify individuals with poor collaterals before stroke or other occlusive disease occurs. In acute ischemic stroke patients, such a biomarker could also aid clinical decision-making and stratification into clinical studies; currently, there is no noninvasive method to assess collateral extent. In addition, the Rabep2 mutants described herein provide a set of mice that models individuals with poor, intermediate, and good collaterals on an otherwise isogenic background for study of the collateral circulation. Table I . Sequence alterations to create mouse lines generated by CRISPR/Cas9 3. Table II . Mendelian ratios of CRISPR-derived mice. 11. Figure VI . Collateral phenotype in mice heterozygous at CRISPR-edited alleles.
SUPPLEMENTAL MATERIAL
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12. Figure VII . Dce1 does not affect outgrowth in aortic ring angiogenesis assay.
13. Figure VIII . Rabep2 deletion does not change expression of early endosome-associated proteins.
Supplemental Materials and Methods
Animals. Congenic strain 7-B6 (CNG7B6) resulted from a recombination while backcrossing CNG5B6 1 mice to BALB/cByJ (BC) to generation N12. PCR markers were used to identify blocks of B6 genotype and crossovers. Heterozygous mice were mated to produce homozygous CNG7B6 and CNG7BC congenic lines. CNG7B6 mice are backcrossed to BALB/cByJ > 11 generations. Four lines of CRISPR/Cas9 genetically modified B6 mice (see Supplemental Table  I) were generated by UNC's Animal Models Core. C57BL/6J (B6) mice with a guanine-toadenine substitution (SNP), a 3-nucleotide deletion (Del3), a one guanine insertion (InsG) or a one guanine deletion (DelG) at rs33080487 (7:126,440,209) in the Rabep2 gene were generated. Mice were genotyped by sequencing PCR products. SNP mice were later genotyped by PCR using the primers F: 5'-GTCCTGGAACTGGCTTTGGTGTC, R-B6: 5'-TAGTCCTTCCTGCAGCTCATCTC, R-BC: 5'-TAGTCCTTCCTGCAGCTCATCTT. Nfatc2ip knockout mice (BC background) were a gift from Dr. Kerri Mowen at Scripps Research Institute (see Supplemental Table I Pial collateral assessment in adult mice. After anesthesia with ketamine (100 mg/kg) and xylazine (10 mg/kg), the thoracic aorta was cannulated retrograde with stretched PE50 tubing and the cortical pial circulation exposed via craniotomy. The vasculature was perfused with heparinized saline containing the vasodilators papaverine (40 g/ml) and sodium nitroprusside (30 g/ml), followed by a small bolus of Evans Blue (50 mg/ml in phosphate buffered saline). Yellow Microfil TM (FlowTech Inc, Carver, MA) was then injected and allowed to cure. Brains were removed and fixed with 4% paraformaldehyde (PFA) overnight and imaged with a stereomicroscope. Pial collateral number was quantified as the number of arteriole-to-arteriole anastomoses cross-connecting outer branches of the MCA and ACA trees, identified after maximal dilation, fixation and filling of the cerebral arterial vasculature with Microfil. While viewing under a stereomicroscope, infusion of Microfil was stopped just before onset of filling of cerebral capillaries (~ 5 micron average diameter) and venules. The stopping point was aided by prior infusion of Evans blue PBS (Figure 1 ). Diameter measurements were made using ImageJ (NIH). Measurements were performed blindly.
Pial collateral assessment in embryonic mice. Mice were paired, and noon on the day that a vaginal plug was detected was considered embryonic day (E) 0.5. On a specified day, embryos were harvested and the brains were fixed in situ in 2% paraformaldehyde in PBS for 2-10 hours. Whole brains were rinsed, permeablized with 0.1 % Triton-X for 12 hours, blocked with 5% donkey serum in PBS, and exposed to anti-CD31antibodies (BD Biosciences, #550274) (1:300) diluted in PBS overnight. Brains were then rinsed and exposed to HRP-conjugated secondary antibody (Jackson ImmunoResearch Laboratories, #111-065-144), horseradish peroxidase (Vectastain RTU #PK-7100, Vector Laboratories), DAB (SK-4100, Vector), and DAB WT nucleotide sequence has a cytosine (complimentary to guanine) at rs33080487. "Del3" mice have an in-frame 3-cytosine/guanine deletion (immediately before red arrow) and are predicted to produce a full-length protein lacking one amino acid. "DelG" mice lack the cytosine/guanine at rs33080487 (immediately before red arrow), which causes a frameshift mutation that produces an immediate stop codon. This is predicted to lead to nonsense-mediated decay (NMD) of the transcript and a functional knockout mouse. "InsG" mice have an inserted cytosine at rs33080487 (red arrow) that causes a frameshift mutation, forming a stop codon that initiates NMD. The "SNP" mice have the BC adenine at rs33080487 (the complimentary thymidine is shown, red arrow) exchanged for the B6 guanine, resulting in the translational substitution R298Q characteristic of the BC strain. Rabep2 expression is reduced in homozygous adult (B) and embryonic (C) DelG cortex. . Each sample is from a different mouse. The calculated molecular weight for Rabep1 (NP_062273.2; http://www.bioinformatics.org/sms/prot_mw.html) is shown. SeeBlue plus 2 standards (St; ThermoFisher) were myosin and bovine serum albumin which migrate on NuPage 7% Trisacetate gels with the apparent molecular weights shown (from package insert). Other labels are as in Figure 2 . B, RNA was extracted from adult cerebral cortexes and cDNA was prepared as described in Methods. Rabep1 expression is compared between WT and DelG mice (n=3 in each group). 
